Zai Lab (ZLAB) Investor Meetings Highlight Chinese Government Reimbursement Fueling M&A - Jefferies
Tweet Send to a Friend
Jefferies analyst Michael Yee reiterated a Buy rating and $225.00 price target on Zai Lab (NASDAQ: ZLAB) after hosting management ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
